Journal of Internal Medicine Concepts & Practice››2021,Vol. 16››Issue (04): 267-269.doi:10.16138/j.1673-6087.2021.04.009
• Research report •Previous ArticlesNext Articles
Received:2021-01-26Online:2021-07-30Published:2022-07-25
| 血常规指标 | 治疗前 | 治疗后 | t | P |
|---|---|---|---|---|
| 红细胞 (×1012/L) | 7.54±1.00 | 6.07±0.78 | 12.968 | <0.001 |
| 血红蛋白 (g/L) | 237.17±13.33 | 183.46±15.65 | 26.626 | <0.001 |
| 红细胞比容 (%) | 70.63±4.61 | 55.90±5.04 | 25.926 | <0.001 |
| 白细胞 (×109/L) | 5.40±1.40 | 5.42±1.63 | -0.082 | 0.935 |
| 血小板 (×109/L) | 135.78±43.16 | 155.06±47.83 | -3.127 | 0.003 |
| 肾功能指标 | n | 治疗前 | 治疗后 | t | P |
|---|---|---|---|---|---|
| 尿酸 (μmol/L) | 54 | 562.76±118.27 | 426.04±103.32 | 9.914 | <0.001 |
| 24 h尿蛋白定量 (mg/24 h) | 41 | 970.22±357.51 | 307.12±180.08 | 11.236 | <0.001 |
| [1] | Villafuerte FC, Corante N. Chronic mountain sickness: clinical aspects, etiology, management, and treatment[J]. High Alt Med Biol, 2016, 17(2): 61-69. doi:10.1089/ham.2016.0031pmid:27218284 |
| [2] | León-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases[J]. High Alt Med Biol, 2005, 6(2): 147-157. pmid:16060849 |
| [3] | Dong Y, Dun B, Wang Dui PB, et al. Therapeutic erythrocytapheresis is effective in treating high altitude polycythemia on the Qinghai-Tibet plateau[J]. Wilderness Environ Med, 2020, 31(4): 426-430. doi:10.1016/j.wem.2020.07.006URL |
| [4] | Rombout-Sestrienkova E, Winkens B, van Kraaij M, et al. A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naive hereditary hemochromatosis[J]. J Clin Apher, 2021, 36(3): 340-347. doi:10.1002/jca.21867pmid:33368569 |
| [5] | 何文华. 干扰素联合羟基脲治疗真性红细胞增多症的疗效观察[J]. 医药前沿, 2012, 2(9): 86. |
| [6] | Evers D, Kerkhoffs JL, Van Egmond L, et al. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis[J]. Transfus Apher Sci, 2013, 48(2): 187. doi:10.1016/j.transci.2013.02.030pmid:23809828 |
| [7] | 方洁, 李啸扬, 李军民, 等. 红细胞单采治疗高原红细胞增多症合并凝血功能异常的临床观察[J]. 实用心脑肺血管病杂志, 2019, 27(S2): 44-46. |
| [8] | 朱澍, 罗布卓玛, 方洁, 等. 西藏地区红细胞单采治疗高原红细胞增多症的疗效研究[J]. 重庆医学, 2021, 50(3): 454-457. |
| [9] | Rombout-Sestrienkova E, Nieman FH, Essers BA, et al. Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial[J]. Transfusion, 2012, 52(3): 470-477. doi:10.1111/j.1537-2995.2011.03292.xpmid:21848963 |
| [10] | Jefferson JA, Escudero E, Hurtado ME, et al. Hyperuricemia,hypertension, and proteinuria associated with high-altitude polycythemia[J]. Am J Kidney Dis, 2002, 39(6): 1135-1142. pmid:12046023 |
| [11] | McCord JM. Oxygen-derived free radicals in postischemic tissue injury[J]. N Engl J Med, 1985, 312(3): 159-163. doi:10.1056/NEJM198501173120305URL |
| [12] | Roch-Ramel F, Guisan B, Diezi J. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles[J]. J Pharmacol Exp Ther, 1997, 280(2): 839-845. pmid:9023298 |
| [13] | 王琰, 努尔曼古丽, 王引虎, 等. 进驻不同海拔高原健康男青年肾功能的变化[J]. 西南国防医药, 2011, 21(1): 24-26. |
| [14] | Yang M, Cui S, Wuren T, et al. Ureteral calculi associated with high-altitude polycythemia[J]. Medicine (Baltimore), 2021, 100(7): e24621. doi:10.1097/MD.0000000000024621URL |
| [15] | Hao Y, Reyes LT, Morris R, et al. Changes of protein levels in human urine reflect the dysregulation of signaling pathways of chronic kidney disease and its complications[J]. Sci Rep, 2020, 10(1): 20743. doi:10.1038/s41598-020-77916-zURL |
| [16] | Vargas-Santos AB, Neogi T. Management of gout and hyperuricemia in CKD[J]. Am J Kidney Dis, 2017, 70(3): 422-439. doi:S0272-6386(17)30579-6pmid:28456346 |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
